SMS
protein-codingspermine synthase, the group of Seven-beta-strand methyltransferase motif containing
Gene summary
This gene encodes a protein belonging to the spermidine/spermin synthase family and catalyzes the production of spermine from spermidine. Pseudogenes of this gene are located on chromosomes 1, 5, 6 and X. Mutations in this gene cause an X-linked intellectual disability called Snyder-Robinson Syndrome (SRS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
- SRS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010664
Submitter: ClinGen
*SMS* is located on chromosome Xp22.11 and encodes spermine synthase, an enzyme involved in the synthesis of the polyamine spermine. *SMS* was first reported in relation to syndromic X-linked intellectual disability Snyder type in 2003 (Cason et al., PMID: 14508504). In affected males, the disorder is characterized by developmental delay, intellectual disability, speech abnormalities, facial dysmorphism, asthenic build, ambulation abnormalities, progressive kyphoscoliosis, early-onset osteoporosis, and seizures. Female carriers are unaffected. Nine unique variants (missense, out-of-frame-splice) that have been reported in 10 probands in 9 publications (PMIDs: 14508504, 18550699, 19206178, 22612257, 23696453, 25888122, 26174906, 26350204, 26761001) are included in this curation. Variants in this gene segregated with disease in at least 12 additional family members. The mechanism of pathogenicity is loss of function. Variants that destabilize the dimer cause loss of the SMS protein, leading to a dearth of spermine. This has been demonstrated by animal models, functional alterations in cells, and analysis of the crystal structure of SMS. In summary, there is definitive evidence supporting the relationship between *SMS* and syndromic X-linked intellectual disability Snyder type. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 16, 2018 (SOP Version 5).
Inheritance Pattern: XL
Disease ID:MONDO:0010664
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010664
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010664
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010664
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: Musculoskeletal
Rationale: Individuals manifest with osteoporosis, and calcium supplementation (with ectopic calcification monitoring) and awareness of fracture risk may be beneficial
Comments: As with other disorders that manifest with seizures, maximal seizure control is beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SMS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004595.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 35 | 2 | 48 | ||
| missense | 9 | 20 | 113 | 4 | 1 | 147 |
| nonsense | 2 | 3 | 5 | |||
| start loss | 2 | 2 | ||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 4 | 18 | 22 | |||
| Total | 10 | 26 | 149 | 39 | 3 | 227 |
Highest pathogenic variant AF is 0.000008914802
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004586.2 | 11 | MANE Select | |
| Ensembl | ENSP00000385746.2 | 11 | MANE Select | |
| RefSeq | NP_001245352.1 | 9 | Standard | |
| Ensembl | ENSP00000368714.1 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| sms | Danio rerio | Structure: spermine biosynthetic process Quality: decreased occurrence abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Arginine and proline metabolism - Homo sapiens (human)
- beta-Alanine metabolism - Homo sapiens (human)
- Glutathione metabolism - Homo sapiens (human)
- Cysteine and methionine metabolism - Homo sapiens (human)
- Spermidine and Spermine Biosynthesis
Biological Process
- methionine metabolic process
- polyamine metabolic process
- spermine biosynthetic process
Molecular Function
- spermine synthase activity
Cellular Component
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404933
- Coding exons
- 11
- Length
- 67108
- Individuals with no LoFs
- 122687
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 122688
- p
- 0.00000408
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.32 | 66 | 144 | 0.457 | 0.0000113 | 2405 |
| Missense (PolyPhen) | 4 | 36.234 | 0.11039 | 678 | ||
| Synonymous | -0.289 | 62 | 59.2 | 1.05 | 0.00000519 | 667 |
| Loss of Function | 3.42 | 1 | 15.5 | 0.0643 | 0.00000121 | 271 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000012 | 0.0000090 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the production of spermine from spermidine and decarboxylated S-adenosylmethionine (dcSAM).;
- Disease
- DISEASE: X-linked syndromic mental retardation Snyder-Robinson type (MRXSSR) [MIM:309583]: Characterized by moderate intellectual deficit, hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis and facial asymmetry. Transmission is X-linked recessive. {ECO:0000269|PubMed:14508504, ECO:0000269|PubMed:18550699, ECO:0000269|PubMed:19206178, ECO:0000269|PubMed:22612257, ECO:0000269|PubMed:23696453, ECO:0000269|PubMed:23897707}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- LoFtool
- 0.0880
- RVIS EVS
- -0.3
- RVIS percentile EVS
- 32.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.943
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |